PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,149 | -26.3% | 1,439 | -3.7% | 0.00% | -33.3% |
| Q2 2023 | $59,865 | -49.3% | 1,494 | -48.4% | 0.01% | -50.0% |
| Q1 2023 | $118,186 | +222.6% | 2,896 | +205.2% | 0.01% | +200.0% |
| Q4 2022 | $36,641 | -22.0% | 949 | +8.5% | 0.00% | -33.3% |
| Q3 2022 | $47,000 | +327.3% | 875 | +380.8% | 0.01% | +500.0% |
| Q2 2022 | $11,000 | +10.0% | 182 | +35.8% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | +25.0% | 134 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | 0.0% | 134 | -4.3% | 0.00% | 0.0% |
| Q3 2021 | $8,000 | 0.0% | 140 | +4.5% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | -11.1% | 134 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | +12.5% | 134 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | 0.0% | 134 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $8,000 | +14.3% | 134 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +250.0% | 134 | +179.2% | 0.00% | – |
| Q1 2020 | $2,000 | -93.3% | 48 | -93.3% | 0.00% | -100.0% |
| Q2 2019 | $30,000 | +900.0% | 712 | +541.4% | 0.01% | +400.0% |
| Q1 2018 | $3,000 | -40.0% | 111 | +15.6% | 0.00% | -66.7% |
| Q1 2016 | $5,000 | -16.7% | 96 | +20.0% | 0.00% | -25.0% |
| Q4 2015 | $6,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |